-
1دورية أكاديمية
المؤلفون: Santini D, Stellato M, De Giorgi U, Pantano F, De Lisi D, Casadei C, Maruzzo M, Bimbatti D, Naglieri E, Buti S, Bersanelli M, De Vivo R, Di Lorenzo G, Sbrana A, Verzoni E, Soraru' M, Fornarini G, Mucciarini C, Grillone F, Mini E, Vignani F, Attademo L, Pignata S, Procopio G
المساهمون: Santini, D, Stellato, M, De Giorgi, U, Pantano, F, De Lisi, D, Casadei, C, Maruzzo, M, Bimbatti, D, Naglieri, E, Buti, S, Bersanelli, M, De Vivo, R, Di Lorenzo, G, Sbrana, A, Verzoni, E, Soraru', M, Fornarini, G, Mucciarini, C, Grillone, F, Mini, E, Vignani, F, Attademo, L, Pignata, S, Procopio, G
مصطلحات موضوعية: cabozantinib, immune-oncology, immunotherapy, renal cell carcinoma, therapeutic sequence, Aged, Anilide, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Renal Cell, Disease Progression, Everolimu, Female, Human, Immune Checkpoint Inhibitor, Italy, Kidney Neoplasm, Male, Middle Aged, Nivolumab, Programmed Cell Death 1 Receptor, Pyridine, Retrospective Studie, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33617179; info:eu-repo/semantics/altIdentifier/wos/WOS:000622345800006; volume:44; issue:3; firstpage:121; lastpage:125; numberofpages:5; journal:AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS; https://hdl.handle.net/11573/1641932Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101735961
-
2دورية أكاديمية
المؤلفون: Daniele G., Arenare L., Scambia G., Pisano C., Sorio R., Breda E., De Placido S., Savarese A., Ferrandina G., Raspagliesi F., Panici P. B., Ferro A., Rimanti A., Cormio G., Lorusso D., Cecere S. C., Scalone S., Marsico V. A., Cardalesi C., Cognetti F., Salutari V., Attademo L., Guizzaro L., Schettino C., Piccirillo M. C., Perrone F., Gallo C., Pignata S.
المساهمون: Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F., Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C., Pignata, S.
مصطلحات موضوعية: Chemotherapy-induced neutropenia, Cytotoxic dosing method, Meta-analysi, Ovarian cancer, Prognostic factor, Retrospective-prospective design, Antineoplastic Combined Chemotherapy Protocol, Carboplatin, Doxorubicin, Female, Human, Kaplan-Meier Estimate, Middle Aged, Neoplasm Staging, Neutropenia, Ovarian Neoplasm, Paclitaxel, Polyethylene Glycol, Prognosi, Progression-Free Survival, Prospective Studie, Retrospective Studies
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000473555400014; volume:154; issue:1; firstpage:83; lastpage:88; numberofpages:6; journal:GYNECOLOGIC ONCOLOGY; http://hdl.handle.net/11588/789586Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85064566909; http://www.elsevier.com/inca/publications/store/6/2/2/8/4/0/index.httTest
الإتاحة: https://doi.org/10.1016/j.ygyno.2019.04.012Test
http://hdl.handle.net/11588/789586Test
http://www.elsevier.com/inca/publications/store/6/2/2/8/4/0/index.httTest -
3
المؤلفون: Carmela Pisano, Francesco Perrone, Giovanni Scambia, Maria Carmela Piccirillo, Roberto Sorio, Sabino De Placido, Valentina Angela Marsico, Sabrina Chiara Cecere, Francesco Cognetti, Sandro Pignata, Anita Rimanti, Laura Arenare, Simona Scalone, Domenica Lorusso, Gennaro Daniele, Enrico Breda, Antonella Ferro, Gabriella Ferrandina, Laura Attademo, Lorenzo Guizzaro, Gennaro Cormio, Vanda Salutari, Clorinda Schettino, Antonella Savarese, Cinzia Cardalesi, Ciro Gallo, Francesco Raspagliesi, Pierluigi Benedetti Panici
المساهمون: Daniele, G., Arenare, L., Scambia, G., Pisano, C., Sorio, R., Breda, E., De Placido, S., Savarese, A., Ferrandina, G., Raspagliesi, F., Panici, P. B., Ferro, A., Rimanti, A., Cormio, G., Lorusso, D., Cecere, S. C., Scalone, S., Marsico, V. A., Cardalesi, C., Cognetti, F., Salutari, V., Attademo, L., Guizzaro, L., Schettino, C., Piccirillo, M. C., Perrone, F., Gallo, C., Pignata, S.
مصطلحات موضوعية: 0301 basic medicine, Oncology, Retrospective-prospective design, Cytotoxic dosing method, Kaplan-Meier Estimate, Polyethylene Glycol, Polyethylene Glycols, Carboplatin, chemistry.chemical_compound, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Prospective Studies, Prospective cohort study, chemotherapy-induced neutropenia, cytotoxic dosing methods, meta-analysis, ovarian cancer, prognostic factors, retrospective-prospective design, Chemotherapy-induced neutropenia, Ovarian Neoplasms, Prognostic factor, Obstetrics and Gynecology, Middle Aged, Prognosis, female genital diseases and pregnancy complications, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, medicine.drug, Human, medicine.medical_specialty, Neutropenia, Paclitaxel, Prognosi, macromolecular substances, Prognostic factors, 03 medical and health sciences, Ovarian cancer, Internal medicine, medicine, Humans, Doxorubicin, Meta-analysi, Progression-free survival, Neoplasm Staging, Retrospective Studies, Cytotoxic dosing methods, Meta-analysis, Antineoplastic Combined Chemotherapy Protocol, business.industry, Ovarian Neoplasm, Cancer, Retrospective cohort study, medicine.disease, Prospective Studie, 030104 developmental biology, Settore MED/40 - GINECOLOGIA E OSTETRICIA, chemistry, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d585d642845303d59d48d63916ae243Test
http://hdl.handle.net/11573/1309583Test